Purchase Order 36C26325P1188

Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the VA's mission to provide specialized cardiovascular care to veterans by supplying advanced heart valve technologies at the Minneapolis, Minnesota facility.

This purchase order represents a continuation of Edwards Lifesciences LLC's established role as a critical supplier of specialized cardiac devices to the VA healthcare system. The company has a documented history of providing highly specialized cardiovascular medical products through both individual purchase orders and larger indefinite delivery contracts with the VA, with individual awards typically ranging from $11,000 to $102,000. As the sole manufacturer of the required TAVR products, Edwards Lifesciences LLC serves as the prime contractor with no subcontractors identified, ensuring the VA's access to specialized medical technologies essential for advanced cardiac interventions across its network.